| Literature DB >> 35079724 |
Timothy Gleeson1, Yos Pagnarith2, Eang Habsreng2, Robert Lindsay1, Michael Hill1, Alexandra Sanseverino1, Viral Patel1, Romolo Gaspari1.
Abstract
BACKGROUND: Dengue is a mosquito-borne viral infection with increasing global prevalence. It is endemic in more than 100 countries, with a heavy burden in Asia. Ultrasound findings including gallbladder wall thickening, ascites, and pleural effusions secondary to plasma leakage have been described in dengue. We aimed to determine if the presence of point-of-care ultrasound findings early in suspected dengue could predict clinical worsening in ambulatory pediatric patients.Entities:
Keywords: Asia; Cambodia; Dengue; Pediatrics; Point-of-care ultrasound; Ultrasound
Year: 2022 PMID: 35079724 PMCID: PMC8777139 DOI: 10.1016/j.lanwpc.2021.100371
Source DB: PubMed Journal: Lancet Reg Health West Pac ISSN: 2666-6065
Figure 1Flow diagram of subject enrollment and follow-up.
Baseline demographics and clinical characteristics of subjects at initial presentation.
| Variable | Enrolled subjects n = 252 | Subjects with follow-up n = 220 | Subjects lost to follow-up n = 32 |
|---|---|---|---|
| Age in yr., mean (SD) | 7·5 (3·8) | 7·6 (3·8) | 6·8 (3·5) |
| Sex | |||
| Male | 136 (53·6%) | 121 (55·0%) | 15 (46·9%) |
| Female | 116 (46·4%) | 99 (45·0%) | 17 (53·1%) |
| Clinical characteristics | |||
| Day of illness, mean (SD) | 3.6 (1·3) | 3.6 (1·3) | 3·5 (1·2) |
| Temp ≥38°C in triage | 117 (46·4%) | 100 (45·5%) | 17 (53·1%) |
| Tachycardia | 99 (39·3%) | 89 (40·5%) | 10 (31·3%) |
| Warning signs present | 157 (62·3%) | 133 (60·5%) | 24 (75·0%) |
| Laboratory studies | |||
| Leukopenia | 88 (41·7%) | 73 (40·1%) | 15 (51·7%) |
| Thrombocytopenia | 77 (36·6%) | 67 (37·0%) | 10 (34·4%) |
| Disposition | |||
| Initial admission | 37 (14·7%) | 30 (13·6%) | 7 (21·9%) |
| Initial discharge | 215 (85·3%) | 190 (86·3%) | 25 (78·1%) |
Ultrasound findings in discharged ambulatory subjects and their association with unexpected return visits or hospitalizations.
| Number with Return Visit or Hospitalization (n/N) | Percent of Return Visit or Hospitalization (%, (95% CI)) | Odds Ratio (OR (95% CI)) | P Value | |
|---|---|---|---|---|
| GB Wall Thickness (>3.0 mm) | 12/18 | 67% (44 – 84) | 11·1 (3·4 – 36·6) | <0.0001 |
| GB Wall Thickness (<3.0 mm) | 30/172 | 17% (12 – 24) | 0.1 (0.04 – 0.3) | <0.0001 |
| Abdominal Fluid (+) | 10/30 | 33% (19 – 51) | 1·0 (0·3 – 3·0) | 0.97 |
| Abdominal Fluid (-) | 32/160 | 20% (15 – 27) | 0.5 (0.2 – 1.2) | 0.11 |
| Pleural Fluid (+) | 1/2 | 50% (9 – 90) | 1·4 (0·05 – 43) | 0.85 |
| Pleural Fluid (-) | 41/188 | 22% (17 – 28) | 0.3 (0.02 – 4.6) | 0.37 |
| Pericardial Fluid (+) | 0/1 | n/a | n/a | n/a |
| Pericardial Fluid (-) | 42/189 | 22% (17 – 29) | n/a | n/a |
| Lung B-Lines (+) | 0/0 | n/a | n/a | n/a |
| Lung B-Lines (-) | 42/190 | 22% (17 – 29) | n/a | n/a |
n = number of subjects with ultrasound finding who had an unplanned return visit or hospitalization. N = total with ultrasound finding discharged.
Figure 2Abnormal ultrasound examinations in study subjects with totals for sub-group categories listed as (n, %). n = number of ultrasounds with finding. % is calculated with denominator = 65 patients with any ultrasound finding. GB = gallbladder.
Figure 3a) Abnormal gallbladder with thickened anterior wall (arrow). b) Normal thin-walled gallbladder. C) Intraperitoneal free fluid (arrow) adjacent to urinary bladder. D) Normal urinary bladder view without free fluid.
Ultrasound findings in subjects admitted at time of initial presentation to hospital.
| Number Admitted with U/S Finding (n/N) | Percent of Admitted with U/S Finding (%, (95% CI)) | Odds Ratio (OR (95% CI)) | P Value | |
|---|---|---|---|---|
| GB Wall Thickness (>3.0 mm) | 14/35 | 40% (26-56) | 4.6 (1.9-11.1) | 0.0006 |
| GB Wall Thickness (<3.0 mm) | 23/217 | 11% (7 – 15) | 0.2 (0.1 – 0.4) | <0.0001 |
| Abdominal Fluid (+) | 14/46 | 30% (19-45) | 2.6 (1.1-6.0) | 0.031 |
| Abdominal Fluid (-) | 23/206 | 11% (8 – 16) | 0.3 (0.1 – 0.6) | 0.0014 |
| Pleural Fluid (+) | 1/3 | 33% (6-79) | n/a | 0.99 |
| Pleural Fluid (-) | 36/249 | 14% (11 – 19) | 0.3 (0.1 – 3.8) | 0.38 |
| Pericardial Fluid (+) | 0/1 | n/a | n/a | 0.99 |
| Pericardial Fluid (-) | 37/251 | 15% (11 – 20) | n/a | n/a |
| Lung B-Lines (+) | 2/2 | 100% (34-100) | n/a | 0.99 |
| Lung B-Lines (-) | 35/250 | 14% (10 – 19) | n/a | n/a |
n = number of subjects with ultrasound finding who were admitted. N = total with ultrasound finding.
Clinical findings in discharged ambulatory subjects and their association with unexpected return visits or hospitalizations.
| Number with Return Visit or Hospitalization (n/N) | Percent of Return Visit or Hospitalization (% (95% CI)) | Odds Ratio (OR (95% CI)) | P Value | |
|---|---|---|---|---|
| Temp > 38°C | 28/87 | 32% (24 – 43) | 3·4 (1·4 – 8·2) | 0.0056 |
| Temp < 38°C | 14/103 | 14% (8 – 22) | 0.3 (0.2 – 0.7) | 0.0027 |
| Increased HR | 23/77 | 30% (21 – 41) | 1·4 (0·6 – 3·4) | 0·41 |
| Normal HR | 19/113 | 17% (11 – 25) | 0.5 (0.2 – 0.9) | 0.035 |
| Increased RR | 31/116 | 27% (20 – 35) | 1·2 (0·5 – 2·9) | 0·69 |
| Normal RR | 11/72 | 15% (9 – 25) | 0.5 (0.2 – 1.1) | 0.07 |
| Any Warning Signs | 24/105 | 23% (16 – 32) | 1·1 (0·6 – 2·2) | 0·78 |
| No Warning Signs | 18/85 | 21% (14 – 31) | 0.9 (0.5 – 1.8) | 0.78 |
| Decreased WBC | 15/55 | 27% (17 – 40) | 1·5 (0·6 – 3·6) | 0·39 |
| Normal WBC | 22/97 | 23% (15 – 32) | 0.8 (0.4 – 1.7) | 0.53 |
| Decreased PLT | 11/42 | 26% (15 – 41) | 1·0 (0·4 – 2·6) | 0·97 |
| Normal PLT | 26/110 | 24% (17 – 32) | 0.9 (0.4 – 2.0) | 0.74 |
| Anorexia | 25/108 | 23% (16 – 32) | 0·9 (0·4 – 2·1) | 0·81 |
| No Anorexia | 17/82 | 21% (13 – 31) | 0.9 (0.4 – 1.7) | 0.69 |
| Nausea | 12/55 | 22% (13 – 34) | 0·7 (0·3 – 1·7) | 0·38 |
| No Nausea | 30/135 | 22% (10 – 30) | 1.0 (0.5 – 2.2) | 0.95 |
| Vomiting | 5/17 | 29% (13 – 53) | 1·6 (0·4 – 7·1) | 0·51 |
| No Vomiting | 37/173 | 21% (16 – 28) | 0.7 (0.2 – 2.0) | 0.45 |
| Rash | 5/12 | 42% (19 – 68) | 2·7 (0·8 – 9·1) | 0·12 |
| No Rash | 37/178 | 21% (15 – 27) | 0.4 (0.1 – 1.2) | 0.10 |
| Myalgia | 5/23 | 22% (10 – 42) | 0·7 (0·2 – 2·4) | 0·56 |
| No Myalgia | 37/167 | 22% (17 – 29) | 1.0 (0.4 – 2.9) | 0.96 |
| Abdominal pain | 16/70 | 23% (15 – 34) | 0·6 (0·2 – 2·4) | 0·50 |
| No Abdominal pain | 26/120 | 22% (15 – 30) | 0.9 (0.5 – 1.9) | 0.85 |
n = number of subjects with finding who had an unplanned return visit or hospitalization. N = total with finding.
Presence of dengue warning signs in subjects admitted or discharged at initial presentation to hospital.
| Admitted | Discharged | |||
|---|---|---|---|---|
| n/N | %, (95% CI) | n/N | %, (95% CI) | |
| Zero Warning Signs | 2/37 | 5% (1 – 19) | 93/215 | 43% (37 – 50) |
| One Warning Sign | 7/37 | 19% (9 – 34) | 90/215 | 42% (35 –49) |
| Two Warning Signs | 21/37 | 57% (41 – 71) | 30/215 | 14% (10 –19) |
| Three Warning Signs | 7/37 | 19% (9 – 34) | 2/215 | 1% (0 – 3) |
Data shown are n (%). n = number of subjects with 0-3 warning signs. N = total number of admitted (or discharged) subjects. Testing for association between number of warning signs and outcome was performed using Fisher's exact test for trend, p = 0.03.